statistiche ricercatore

Nome	#
Long-Term Evaluation (Efficacy and Safety) of Infliximab in the Treatment of Persistently Active Juvenile Idiopathic Arthritis (JIA), Refractory to Standard Treatments	179
Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy	133
Skeletal mineralization in a prepubertal female population affected by juvenile idiopathic arthritis	124
Efficacy of a second TNFAlpha blocker when the first one failed in patients with juvenile idiopathic arthritis (JIA) treated with Infliximab, Etanercept and Adalimubab	116
Anti-Cyclic Citrullinated Peptide Antibodies in Juvenile Idiopathic Arthritis (jia). A Monocentric Cross-Sectional Study	101
Side Effects of Anti-Tnfα Therapy in Jia, in an Open Monocentric Prospective Study of 151 Patients	100
Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis : results of an open-label prospective study	91
Totale	844

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	69	0	0	0	0	0	19	11	3	18	7	10	1
2020/2021	98	0	7	13	0	7	6	8	6	16	3	27	5
2021/2022	49	8	0	0	0	4	3	10	3	6	2	4	9
2022/2023	104	13	7	4	26	10	23	0	7	9	1	3	1
2023/2024	62	1	6	8	2	11	12	4	4	0	0	7	7
2024/2025	77	5	21	0	29	17	5	0	0	0	0	0	0
Totale													844

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca